Speaker Profile
M.D.,Ph.D., Director, CIRM UC San Diego Stem Cell Clinic; Prof. of Medicine, UCSD Health
Biography
Catriona Jamieson is a leading physician scientist who has specialized in myeloproliferative neoplasms (MPNs) and leukemia. She discovered missplicing, RNA hyperediting, and splice isoform switching as mechanisms governing human cancer stem cell maintenance in selective niches. These discoveries have helped to shed light on the underlying mechanisms of cancer and have opened up new avenues for targeted therapies. Dr. Jamieson's contributions to the field of precision medicine include her pivotal role in the rescue and development of the JAK inhibitor fedratinib for the treatment of myelofibrosis. Additionally, she is known for her unwavering dedication to advancing innovative therapies and her outstanding leadership as the director of the Sanford Stem Cell Institute at UCSD and as a co-founder of Impact Biosciences and Aspera Biomedicines.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair: Catriona Jamieson, UCSD
PMWC Award Ceremony Honorees
• Judy Faulkner, Epic
• Svetlana Mojsov, The Rockefeller University (GLP-1)
• Alexis C. Komor, UCSD
Opening Talk
• Catriona Jamieson, UC San Diego
GLP-1: From Hormone Discovery to a Global Therapeutic Revolution
• Svetlana Mojsov, The Rockefeller University
What’s Next at Epic?
• Peter DeVault, Epic
Modified mRNA, siRNA, ASOs
• Chair: Alexis C. Komor, UC San Diego
• Niren Murthy, UC Berkeley
• Gene Yeo, UC San Diego
• Reuben Harris, UT Health San Antonio
Stem Cell–Targeted Therapeutics: Small Molecules & Biologics
• Chair: Catriona Jamieson, UC San Diego
• Irving L. Weissman, Stanford
In Vivo Gene Therapies
• Chair: Gene Yeo, UC San Diego
• Mark A. Kay, Stanford
• David Schaffer, UC Berkeley
Diagnostics, Prognostics, and Patient Stratification
• Chair: Ezra Cohen, Tempus
• Eitan Ruppin, NIH
• Danielle Hamel, Tempus
• David Ledbetter, Florida State University
• Ludmil Alexandrov, UC San Diego
Closing
• Catriona Jamieson, UC San Diego
